Bayer is now facing lawsuits from around 11,200 plaintiffs over the health implications of Roundup and Ranger Pro, its glyphosate-based weedkillers.

The German life science giant revealed the figure Wednesday as it announced its results for fiscal 2018. Full-year sales were up 13% and EBITDA before special items up 2.8%, but full-year net earnings were down more than three-quarters due to a $3.8 billion impairment charge and a $2.3 billion charge in connection with Bayer’s acquisition of Roundup maker Monsanto.